Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05964699 · ClinicalTrials.gov registry record · NA

The Use of a Non-Incised Minimally Invasive Flap Procedure in Conjunction With Emdogain® MI Compared to Traditional SRCP

A NA study of Periodontitis and Attachment Loss, Periodontal, sponsored by Texas A&M University.

Recruiting
Registry status
NA
Development phase
32
Enrollment target
1
Study location

NCT05964699: Recruiting NA study of Periodontitis and Attachment Loss, Periodontal, sponsored by Texas A&M University.

NCT05964699 is a NA study of Periodontitis and Attachment Loss, Periodontal that is actively recruiting participants, run by Texas A&M University. The registered enrollment target is 32 participants, below the 112-participant average among 11 other Periodontitis trials with a reported enrollment target (71% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05964699, a NA study of Periodontitis and Attachment Loss, Periodontal, is actively recruiting participants, sponsored by Texas A&M University.

RECRUITING
Registry status
NA
Development phase
32 participants
Enrollment target
1
Study location

Study Summary

This study is designed to evaluate the use of Emdogain® MI in a procedure where a significant portion of the lining of the sulcus is removed by curettage (similar to the traditional clinical procedure described as "gingival curettage") to the point of tissue mobility. This will be designated as a "non-incised minimally invasive flap access procedure". A videoscope will be utilized to assist with the requirement to adequately visualize and debride the root surface. This research project will define the approach used as a "non-incised minimally invasive flap access" approach and will be a modification of recognized minimally invasive techniques. This modification will be made by Dr. Harrel who first describe the minimally invasive periodontal approach and defined minimally invasive periodontal procedures in 1995.

Interventions

  • PROCEDURE Minimally invasive periodontal therapy with use of Emdogain
  • PROCEDURE Minimally invasive periodontal therapy without the use of Emdogain

Study Locations (1)

Texas

  • Texas A&M School of Dentistry - Dallas

Trial Details

FieldValue
Enrollment Target 32 participants
Start Date 2023-07-31
Est. Completion 2025-07-31
Phase NA
Texas A&M University

95 total trials

What NCT05964699 shows while recruiting

NCT05964699 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 32 participants, a relatively small participant target, below the 112-participant average among 11 other Periodontitis trials with a reported enrollment target (71% lower).

The record links to 2 conditions, with Periodontitis appearing as the primary indexed condition, and to 2 interventions - of which Minimally invasive periodontal therapy with use of Emdogain is the first listed.

NCT05964699 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT05964699 about?

NCT05964699 is a clinical study titled "The Use of a Non-Incised Minimally Invasive Flap Procedure in Conjunction With Emdogain® MI Compared to Traditional SRCP". This study is designed to evaluate the use of Emdogain® MI in a procedure where a significant portion of the lining of the sulcus is removed by curettage (similar to the traditional clinical procedure described as "gingival curettage") to the point of tissue mobility. This will be designated as a "n...

What is the current status of trial NCT05964699?

This trial is currently recruiting. It is a NA study. The enrollment target is 32 participants. The study started on 2023-07-31. Estimated completion is 2025-07-31.

What conditions does trial NCT05964699 study?

This clinical trial studies the following conditions: Periodontitis, Attachment Loss, Periodontal.

What interventions are being tested in trial NCT05964699?

The interventions under investigation include: Minimally invasive periodontal therapy with use of Emdogain (PROCEDURE), Minimally invasive periodontal therapy without the use of Emdogain (PROCEDURE).

Who is sponsoring clinical trial NCT05964699?

This trial is sponsored by Texas A&M University, which has 95 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05964699 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Periodontitis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05964699's enrollment target sits among peer trials

32 11th of 11 higher than 1 of 11 other Periodontitis trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Periodontitis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02445781 · 32 participants · Early Phase 1

    Differing Levels of Hypoglycemia

  • NCT02792270 · 32 participants · NA

    Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT

  • NCT03068910 · 32 participants · Early Phase 1

    Hyperandrogenemia and Altered Day-night LH Pulse Patterns

  • NCT03208868 · 32 participants · NA

    Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05964699, the US trial registry maintained by the National Library of Medicine. NCT05964699 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.